{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:05:48Z","timestamp":1794571548526,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006402","name":"ALS Therapy Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13024-018-0288-y","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T08:50:23Z","timestamp":1539679823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice"],"prefix":"10.1186","volume":"13","author":[{"given":"Sander","family":"Beel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Herdewyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheem","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"De Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Moisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Robberecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludo","family":"Van Den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4010-2357","authenticated-orcid":false,"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"288_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S1474-4422(05)70223-4","volume":"4","author":"D Neary","year":"2005","unstructured":"Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4:771\u201380.","journal-title":"Lancet Neurol"},{"key":"288_CR2","doi-asserted-by":"publisher","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17085.","journal-title":"Nat Rev Dis Primers"},{"key":"288_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130\u20133.","journal-title":"Science"},{"key":"288_CR4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084\u201398.","journal-title":"Lancet"},{"key":"288_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572\u20134.","journal-title":"Nat Genet"},{"key":"288_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","volume":"7","author":"VM Van Deerlin","year":"2008","unstructured":"Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen-Plotkin AS, Martinez-Lage M, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409\u201316.","journal-title":"Lancet Neurol"},{"key":"288_CR7","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668\u201372.","journal-title":"Science"},{"key":"288_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nature05017","volume":"442","author":"M Cruts","year":"2006","unstructured":"Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920\u20134.","journal-title":"Nature"},{"key":"288_CR9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916\u20139.","journal-title":"Nature"},{"key":"288_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-007-0223-8","volume":"114","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR. The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol. 2007;114:49\u201354.","journal-title":"Acta Neuropathol"},{"key":"288_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1083\/jcb.200712039","volume":"181","author":"P Van Damme","year":"2008","unstructured":"Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J, Carmeliet P, Van Den Bosch L, Robberecht W. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol. 2008;181:37\u201341.","journal-title":"J Cell Biol"},{"key":"288_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1212\/01.wnl.0000325058.10218.fc","volume":"71","author":"R Ghidoni","year":"2008","unstructured":"Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology. 2008;71:1235\u20139.","journal-title":"Neurology"},{"key":"288_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ana.21621","volume":"65","author":"K Sleegers","year":"2009","unstructured":"Sleegers K, Brouwers N, Van Damme P, Engelborghs S, Gijselinck I, van der Zee J, Peeters K, Mattheijssens M, Cruts M, Vandenberghe R, et al. Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol. 2009;65:603\u20139.","journal-title":"Ann Neurol"},{"key":"288_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nbd.2008.11.008","volume":"33","author":"L Benussi","year":"2009","unstructured":"Benussi L, Ghidoni R, Pegoiani E, Moretti DV, Zanetti O, Binetti G. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol Dis. 2009;33:379\u201385.","journal-title":"Neurobiol Dis"},{"key":"288_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/01.wnl.0000289191.54852.75","volume":"71","author":"K Sleegers","year":"2008","unstructured":"Sleegers K, Brouwers N, Maurer-Stroh S, van Es MA, Van Damme P, van Vught PW, van der Zee J, Serneels S, De Pooter T, Van den Broeck M, et al. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology. 2008;71:253\u20139.","journal-title":"Neurology"},{"key":"288_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tins.2014.04.003","volume":"37","author":"TL Petkau","year":"2014","unstructured":"Petkau TL, Leavitt BR. Progranulin in neurodegenerative disease. Trends Neurosci. 2014;37:388\u201398.","journal-title":"Trends Neurosci"},{"key":"288_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12031-011-9553-z","volume":"45","author":"L De Muynck","year":"2011","unstructured":"De Muynck L, Van Damme P. Cellular effects of progranulin in health and disease. J Mol Neurosci. 2011;45:549\u201360.","journal-title":"J Mol Neurosci"},{"key":"288_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajpath.2010.11.002","volume":"178","author":"F Pickford","year":"2011","unstructured":"Pickford F, Marcus J, Camargo LM, Xiao Q, Graham D, Mo JR, Burkhardt M, Kulkarni V, Crispino J, Hering H, Hutton M. Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am J Pathol. 2011;178:284\u201395.","journal-title":"Am J Pathol"},{"key":"288_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","volume":"165","author":"H Lui","year":"2016","unstructured":"Lui H, Zhang J, Makinson SR, Cahill MK, Kelley KW, Huang HY, Shang Y, Oldham MC, Martens LH, Gao F, et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell. 2016;165:921\u201335.","journal-title":"Cell"},{"key":"288_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1084\/jem.20091568","volume":"207","author":"F Yin","year":"2010","unstructured":"Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, Beal MF, et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med. 2010;207:117\u201328.","journal-title":"J Exp Med"},{"key":"288_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.11.032","volume":"231","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Matsuwaki T, Yamanouchi K, Nishihara M. Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice. Neuroscience. 2013;231:49\u201360.","journal-title":"Neuroscience"},{"key":"288_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nm.3672","volume":"20","author":"SS Minami","year":"2014","unstructured":"Minami SS, Min SW, Krabbe G, Wang C, Zhou Y, Asgarov R, Li Y, Martens LH, Elia LP, Ward ME, et al. Progranulin protects against amyloid beta deposition and toxicity in Alzheimer's disease mouse models. Nat Med. 2014;20:1157\u201364.","journal-title":"Nat Med"},{"key":"288_CR23","doi-asserted-by":"publisher","first-page":"11126","DOI":"10.1523\/JNEUROSCI.6244-10.2011","volume":"31","author":"L Tapia","year":"2011","unstructured":"Tapia L, Milnerwood A, Guo A, Mills F, Yoshida E, Vasuta C, Mackenzie IR, Raymond L, Cynader M, Jia W, Bamji SX. Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses. J Neurosci. 2011;31:11126\u201332.","journal-title":"J Neurosci"},{"key":"288_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.nbd.2011.10.016","volume":"45","author":"TL Petkau","year":"2012","unstructured":"Petkau TL, Neal SJ, Milnerwood A, Mew A, Hill AM, Orban P, Gregg J, Lu G, Feldman HH, Mackenzie IR, et al. Synaptic dysfunction in progranulin-deficient mice. Neurobiol Dis. 2012;45:711\u201322.","journal-title":"Neurobiol Dis"},{"key":"288_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1326-7-33","volume":"7","author":"J Gass","year":"2012","unstructured":"Gass J, Lee WC, Cook C, Finch N, Stetler C, Jansen-West K, Lewis J, Link CD, Rademakers R, Nykjaer A, Petrucelli L. Progranulin regulates neuronal outgrowth independent of Sortilin. Mol Neurodegener. 2012;7:33.","journal-title":"Mol Neurodegener"},{"key":"288_CR26","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/j.neurobiolaging.2013.04.022","volume":"34","author":"L De Muynck","year":"2013","unstructured":"De Muynck L, Herdewyn S, Beel S, Scheveneels W, Van Den Bosch L, Robberecht W, Van Damme P. The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding. Neurobiol Aging. 2013;34:2541\u20137.","journal-title":"Neurobiol Aging"},{"key":"288_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s13238-010-0067-1","volume":"1","author":"X Gao","year":"2010","unstructured":"Gao X, Joselin AP, Wang L, Kar A, Ray P, Bateman A, Goate AM, Wu JY. Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3beta. Protein Cell. 2010;1:552\u201362.","journal-title":"Protein Cell"},{"key":"288_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1326-5-41","volume":"5","author":"BP Chitramuthu","year":"2010","unstructured":"Chitramuthu BP, Baranowski DC, Kay DG, Bateman A, Bennett HP. Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of survival motor neuron 1. Mol Neurodegener. 2010;5:41.","journal-title":"Mol Neurodegener"},{"key":"288_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrn.2017.36","volume":"18","author":"AW Kao","year":"2017","unstructured":"Kao AW, McKay A, Singh PP, Brunet A, Huang EJ. Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci. 2017;18:325\u201333.","journal-title":"Nat Rev Neurosci"},{"key":"288_CR30","first-page":"969","volume":"26","author":"Y Tanaka","year":"2017","unstructured":"Tanaka Y, Suzuki G, Matsuwaki T, Hosokawa M, Serrano G, Beach TG, Yamanouchi K, Hasegawa M, Nishihara M. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes. Hum Mol Genet. 2017;26:969\u201388.","journal-title":"Hum Mol Genet"},{"key":"288_CR31","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","volume":"26","author":"S Beel","year":"2017","unstructured":"Beel S, Moisse M, Damme M, De Muynck L, Robberecht W, Van Den Bosch L, Saftig P, Van Damme P. Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo. Hum Mol Genet. 2017;26:2850\u201363.","journal-title":"Hum Mol Genet"},{"key":"288_CR32","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","volume":"20","author":"BM Evers","year":"2017","unstructured":"Evers BM, Rodriguez-Navas C, Tesla RJ, Prange-Kiel J, Wasser CR, Yoo KS, McDonald J, Cenik B, Ravenscroft TA, Plattner F, et al. Lipidomic and transcriptomic basis of lysosomal dysfunction in Progranulin deficiency. Cell Rep. 2017;20:2565\u201374.","journal-title":"Cell Rep"},{"key":"288_CR33","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","volume":"26","author":"C Valdez","year":"2017","unstructured":"Valdez C, Wong YC, Schwake M, Bu G, Wszolek ZK, Krainc D. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Hum Mol Genet. 2017;26:4861\u201372.","journal-title":"Hum Mol Genet"},{"key":"288_CR34","first-page":"845","volume":"127","author":"JK Gotzl","year":"2014","unstructured":"Gotzl JK, Mori K, Damme M, Fellerer K, Tahirovic S, Kleinberger G, Janssens J, van der Zee J, Lang CM, Kremmer E, et al. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Acta Neuropathol. 2014;127:845\u201360.","journal-title":"Acta Neuropathol"},{"key":"288_CR35","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1084\/jem.20160999","volume":"214","author":"MC Chang","year":"2017","unstructured":"Chang MC, Srinivasan K, Friedman BA, Suto E, Modrusan Z, Lee WP, Kaminker JS, Hansen DV, Sheng M. Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation. J Exp Med. 2017;214:2611\u201328.","journal-title":"J Exp Med"},{"key":"288_CR36","doi-asserted-by":"publisher","first-page":"e13368","DOI":"10.1371\/journal.pone.0013368","volume":"5","author":"AS Laird","year":"2010","unstructured":"Laird AS, Van Hoecke A, De Muynck L, Timmers M, Van Den Bosch L, Van Damme P, Robberecht W. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS One. 2010;5:e13368.","journal-title":"PLoS One"},{"key":"288_CR37","doi-asserted-by":"publisher","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009;106:18809\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"288_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1326-9-24","volume":"9","author":"S Herdewyn","year":"2014","unstructured":"Herdewyn S, Cirillo C, Van Den Bosch L, Robberecht W, Vanden Berghe P, Van Damme P. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Mol Neurodegener. 2014;9:24.","journal-title":"Mol Neurodegener"},{"key":"288_CR39","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.neurobiolaging.2013.03.027","volume":"34","author":"S Herdewyn","year":"2013","unstructured":"Herdewyn S, De Muynck L, Van Den Bosch L, Robberecht W, Van Damme P. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats. Neurobiol Aging. 2013;34:2302\u20133.","journal-title":"Neurobiol Aging"},{"key":"288_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"288_CR41","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Research. 2015;4:1521.","journal-title":"F1000Research"},{"key":"288_CR42","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288\u201397.","journal-title":"Nucleic Acids Res"},{"key":"288_CR43","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nm.3108","volume":"19","author":"H Cho","year":"2013","unstructured":"Cho H, Proll SC, Szretter KJ, Katze MG, Gale M Jr, Diamond MS. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013;19:458\u201364.","journal-title":"Nat Med"},{"key":"288_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1089\/ars.2012.4620","volume":"18","author":"YC Yang","year":"2013","unstructured":"Yang YC, Chou HY, Shen TL, Chang WJ, Tai PH, Li TK. Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis. Antioxid Redox Signal. 2013;18:1129\u201340.","journal-title":"Antioxid Redox Signal"},{"key":"288_CR45","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-013-1181-y","volume":"126","author":"IR Mackenzie","year":"2013","unstructured":"Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D, Neumann M. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 2013;126:859\u201379.","journal-title":"Acta Neuropathol"},{"key":"288_CR46","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awx198","volume":"140","author":"BP Chitramuthu","year":"2017","unstructured":"Chitramuthu BP, Bennett HPJ, Bateman A. Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease. Brain. 2017;140:3081\u2013104.","journal-title":"Brain"},{"key":"288_CR47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1083\/jcb.200908115","volume":"187","author":"JS Ju","year":"2009","unstructured":"Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol. 2009;187:875\u201388.","journal-title":"J Cell Biol"},{"key":"288_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12974-017-0928-0","volume":"14","author":"S Torres-Odio","year":"2017","unstructured":"Torres-Odio S, Key J, Hoepken HH, Canet-Pons J, Valek L, Roller B, Walter M, Morales-Gordo B, Meierhofer D, Harter PN, et al. Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation. J Neuroinflammation. 2017;14:154.","journal-title":"J Neuroinflammation"},{"key":"288_CR49","doi-asserted-by":"publisher","first-page":"e1002773","DOI":"10.1371\/journal.ppat.1002773","volume":"8","author":"AV Pilar","year":"2012","unstructured":"Pilar AV, Reid-Yu SA, Cooper CA, Mulder DT, Coombes BK. GogB is an anti-inflammatory effector that limits tissue damage during Salmonella infection through interaction with human FBXO22 and Skp1. PLoS Pathog. 2012;8:e1002773.","journal-title":"PLoS Pathog"},{"key":"288_CR50","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.15252\/embj.201797568","volume":"36","author":"FB Gao","year":"2017","unstructured":"Gao FB, Almeida S, Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 2017;36:2931\u201350.","journal-title":"EMBO J"},{"key":"288_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11060-011-0758-3","volume":"107","author":"A Arivazhagan","year":"2012","unstructured":"Arivazhagan A, Kumar DM, Sagar V, Patric IR, Sridevi S, Thota B, Srividya MR, Prasanna K, Thennarasu K, Mondal N, et al. Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor. J Neuro-Oncol. 2012;107:289\u201397.","journal-title":"J Neuro-Oncol"},{"key":"288_CR52","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/onc.2014.92","volume":"34","author":"I Bandey","year":"2015","unstructured":"Bandey I, Chiou SH, Huang AP, Tsai JC, Tu PH. Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness. Oncogene. 2015;34:1853\u201364.","journal-title":"Oncogene"},{"key":"288_CR53","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/brain\/awx060","volume":"140","author":"AE Arrant","year":"2017","unstructured":"Arrant AE, Filiano AJ, Unger DE, Young AH, Roberson ED. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia. Brain. 2017;140:1447\u201365.","journal-title":"Brain"},{"key":"288_CR54","doi-asserted-by":"publisher","first-page":"e97032","DOI":"10.1371\/journal.pone.0097032","volume":"9","author":"JM Van Kampen","year":"2014","unstructured":"Van Kampen JM, Baranowski D, Kay DG. Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease. PLoS One. 2014;9:e97032.","journal-title":"PLoS One"},{"key":"288_CR55","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1172\/JCI63113","volume":"122","author":"LH Martens","year":"2012","unstructured":"Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B, Min SW, Gan L, Finkbeiner S, Huang EJ, Farese RV Jr. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest. 2012;122:3955\u20139.","journal-title":"J Clin Invest"},{"key":"288_CR56","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/brain\/awv079","volume":"138","author":"M Kanazawa","year":"2015","unstructured":"Kanazawa M, Kawamura K, Takahashi T, Miura M, Tanaka Y, Koyama M, Toriyabe M, Igarashi H, Nakada T, Nishihara M, et al. Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke. Brain. 2015;138:1932\u201348.","journal-title":"Brain"},{"key":"288_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1742-2094-10-105","volume":"10","author":"Y Egashira","year":"2013","unstructured":"Egashira Y, Suzuki Y, Azuma Y, Takagi T, Mishiro K, Sugitani S, Tsuruma K, Shimazawa M, Yoshimura S, Kashimata M, et al. The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J Neuroinflammation. 2013;10:105.","journal-title":"J Neuroinflammation"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-018-0288-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:14:31Z","timestamp":1571166871000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-018-0288-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1186\/s13024-018-0288-y","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"3 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of the KU Leuven (P148\/2011).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"55"}}